Medicare Enrolled

Dr. Orlando Florete, M.D.

Pain Medicine · Jacksonville, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3100 UNIVERSITY BLVD S, Jacksonville, FL 32216
9042748813
In practice since 2006 (19 years)
NPI: 1104922541 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Florete from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Florete? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Florete

Dr. Orlando Florete is a pain medicine specialist in Jacksonville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Florete performed 1,996 Medicare services across 884 unique beneficiaries.

Between the years covered by Open Payments, Dr. Florete received a total of $224,837 from 61 pharmaceutical and/or device companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Florete is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 43% volume in FL $224,837 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 58430 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,996
Medicare services
Top 43% in FL for pain medicine
884
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 715 $86 $242
Steroid injection (triamcinolone) 445 $1 $6
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha 207 $63 $162
Testing for presence of drug, read by direct observation 154 $12 $36
Office visit, established patient (20-29 min) 86 $60 $171
Joint injection, major joint 43 $56 $155
Administration of psychological or neuropsychological test by technician, first 30 minutes 38 $24 $64
New patient office visit, complex (60-74 min) 38 $140 $430
Evaluation of psychological test, first hour 37 $38 $236
Evaluation of neuropsychological test, first hour 37 $13 $256
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 37 $26 $68
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 25 $64 $607
Injection of substance into lower spine canal using imaging guidance 22 $189 $485
Testing of autonomic nervous system function and heart rate response to deep breathing 22 $62 $168
Testing of autonomic (sympathetic) nervous system function 22 $89 $236
Injection of substance into middle or upper spine canal using imaging guidance 20 $179 $504
Ultrasound study of arm and leg arteries 20 $57 $164
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 14 $205 $1,151
Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) 14 $23 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$224,837
Total received (2018-2024)
Avg $32,120/year across 7 years
Top 1% in FL for pain medicine
61
Companies
633
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$215,883 (96.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,954 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,522
2023
$20,077
2022
$6,805
2021
$1,634
2020
$4,516
2019
$50,066
2018
$140,217

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$85,665
Amgen Inc.
$45,877
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40,881
IDORSIA PHARMACEUTICALS US INC
$23,956
AstraZeneca Pharmaceuticals LP
$12,418
Pernix Therapeutics Holdings, Inc.
$7,993
Collegium Pharmaceutical, Inc.
$1,505
Medtronic, Inc.
$550
ABBVIE INC.
$523
BioDelivery Sciences International, Inc.
$399
SPR Therapeutics, Inc
$343
Averitas Pharma Inc.
$276
Abbott Laboratories
$263
Biohaven Pharmaceutical Holding Company Ltd.
$262
PFIZER INC.
$255
GRT US Holding, Inc.
$251
Novartis Pharmaceuticals Corporation
$244
Stimwave Technologies Incorporated
$237
AbbVie Inc.
$217
SI-BONE, Inc.
$206
Nuvectra Corporation
$203
Neuronetics, Inc.
$198
Medtronic USA, Inc.
$191
Lundbeck LLC
$179
Biohaven Pharmaceuticals, Inc.
$163
Lilly USA, LLC
$158
Boston Scientific Corporation
$122
Horizon Pharma plc
$120
Merck Sharp & Dohme LLC
$109
RedHill Biopharma Inc.
$108
Almatica Pharma LLC
$105
Nevro Corp.
$105
Flowonix Medical Incorporated
$97
Masimo Corporation
$55
Alnylam Pharmaceuticals Inc.
$49
PROTEGA PHARMACEUTIALS INC
$44
Hikma Pharmaceuticals USA
$43
Avanos Medical
$38
Purdue Pharma L.P.
$35
Valinor Pharma, LLC
$32
Virtus Pharmaceuticals LLC
$28
INSYS Therapeutics Inc
$26
Allergan Inc.
$26
Team 1, Llc
$23
Orexo US, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$19
Bioventus LLC
$18
Epimed International, Inc
$18
Pacira Pharmaceuticals Incorporated
$17
Flexion Therapeutics, Inc.
$16
Amneal Pharmaceuticals LLC
$15
Kaleo, Inc.
$15
Curonix LLC
$15
Scilex Pharmaceuticals Inc.
$15
Trevena, Inc.
$14
Allergan, Inc.
$14
PAINTEQ LLC
$14
Orthogenrx Inc.
$13
ASSERTIO THERAPEUTICS, INC.
$13
Vertical Pharmaceuticals, LLC
$12
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 76.7% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AMITIZA · ASCENDA · Aimovig · Algovita · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · Bridge · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Catheters and Needles · EMGALITY · ETERNA · Evzio · Exparel · FLECTOR · GELSYN-3 · GIVLAARI · GRALISE · GenVisc 850 · Gralise · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Kloxxado · LACTULOSE · LEVORPHANOL TARTRATE · LORZONE · LUCEMYRA · LYVISPAH · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · OLINVYK · PAINTEQ · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Patient SafetyNet System · Proclaim Family of SCS IPGs · Prometra II · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · ROXYBOND · RoxyBond · SCS IPGs · SPECIFY · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · STANDARD RF DISPOSABLES · SYMPROIC · SYNCHROMEDII · SYNDROS · Senza · Senza Spinal Cord Stimulation System · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zubsolv · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pain medicine in FL.

Equivalent to $11,264 per 100 Medicare services performed
Looking for a pain medicine specialist in Jacksonville?
Compare pain medicines in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
34
Per 100K population
3.4
County median income
$68,447
Nearest hospital
HCA FLORIDA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Florete is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Florete experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Florete performed 715 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Florete receive payments from pharmaceutical companies?
Yes. Dr. Florete received a total of $224,837 from 61 companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Florete's costs compare to other pain medicines in Jacksonville?
Dr. Florete's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Florete) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →